You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TCR-T

Showing 26 - 50 of 8,301
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Juvenile Myelomonocytic Leukemia, Recurrent Acute Biphenotypic Leukemia, Recurrent Acute Undifferentiated Leukemia Trial in

Suspended
  • Juvenile Myelomonocytic Leukemia
  • +27 more
  • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 11, 2023

Hepatocellular Carcinoma Trial in Beijing, Shanghai, Shenyang (SCG101, PD1/PD-L1 checkpoint inhibitor)

Recruiting
  • Hepatocellular Carcinoma
  • SCG101
  • PD1/PD-L1 checkpoint inhibitor
  • Beijing, China
  • +3 more
May 7, 2022

CMV Infection After Allogenic HSCT Trial in Beijing (CMV-TCR-T cells)

Recruiting
  • CMV Infection After Allogenic HSCT
  • CMV-TCR-T cells
  • Beijing, Beijing, China
    Chinese PLA General Hospital
Dec 5, 2021

Prostate Carcinoma, Prostate Small Cell Neuroendocrine Carcinoma, Stage III Prostate Cancer AJCC v8 Trial in Seattle (drug,

Not yet recruiting
  • Prostate Carcinoma
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2023

Advanced Solid Tumors Trial in Chongqing (TC-N201 cells, IL-2, Fludarabine)

Recruiting
  • Advanced Solid Tumors
  • TC-N201 cells
  • +4 more
  • Chongqing, China
    TCRCure Biopharma Ltd.
May 25, 2023

Cervical Cancer, Throat Cancer, Oropharynx Cancer Trial in New Brunswick (E7 TCR-T cells)

Not yet recruiting
  • Cervical Cancer
  • +20 more
  • E7 TCR-T cells
  • New Brunswick, New Jersey
  • +1 more
Jan 18, 2023

Solid Tumor Trial in Guangzhou (tumor-specific TCR-T cells, Interleukin-2)

Recruiting
  • Solid Tumor
  • Guangzhou, Gaungdong, China
    Sun Yat-sen University Cancer Center
Oct 21, 2021

Hepatocellular Carcinoma Trial in Singapore (mRNA HBV/TCR T-cells)

Recruiting
  • Hepatocellular Carcinoma
  • mRNA HBV/TCR T-cells
  • Singapore, Singapore
    Singapore General Hospital
Jun 27, 2022

Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)

Not yet recruiting
  • Triple Negative Breast Cancer
  • Aldesleukin
  • +12 more
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 9, 2023

Uterine Cervical Tumors Trial run by the NCI (E7 T-Cell Receptor (TCR))

Terminated
Has Results
  • Uterine Cervical Neoplasms
  • E7 T-Cell Receptor (TCR)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 7, 2021

Allogeneic Hematopoietic Stem Cell Transplantation, CMV Infection Trial in Beijing (CMV-TCR-T cells)

Recruiting
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • CMV Infection
  • CMV-TCR-T cells
  • Beijing, Beijing, China
    Peking University Institute of Hematology,People's hospital Peki
Oct 11, 2021

Synovial Sarcoma Trial in Houston (Fludarabine phosphate, NY-ESO-1 TCR/IL-15 NK, Cyclophosphamide)

Not yet recruiting
  • Synovial Sarcoma
  • Fludarabine phosphate
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Oct 9, 2023

Nonsmall Cell Lung Cancer, Solid Tumor, Adult Trial in Guanzhou (TCR-T cells)

Recruiting
  • Nonsmall Cell Lung Cancer
  • Solid Tumor, Adult
  • TCR-T cells
  • Guanzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Sep 19, 2021

Papillomavirus Infections, Oropharyngeal Tumors Trial run by the NCI (E7 T-Cell Receptor (TCR))

Terminated
Has Results
  • Papillomavirus Infections
  • Oropharyngeal Neoplasms
  • E7 T-Cell Receptor (TCR)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 3, 2022

HIV/AIDS Trial in Guangzhou (Chidamide with CAR-T or TCR-T cell therapy)

Completed
  • HIV/AIDS
  • Chidamide with CAR-T or TCR-T cell therapy
  • Guangzhou, Guangdong, China
    Guangzhou 8th People's Hospital
Jul 19, 2021

Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Cell Carcinoma Trial (LioCyx-M, Lenvatinib)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • (no location specified)
Jan 4, 2022

Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Houston (Neoantigen specific TCR-T cell drug product,

Recruiting
  • Gynecologic Cancer
  • +11 more
  • Neoantigen specific TCR-T cell drug product
  • Aldesleukin (IL-2)
  • Houston, Texas
    MD Anderson Cancer Center
Jul 27, 2022

Pancreatic Cancer, Pancreatic Tumors, Pancreatic Ductal Adenocarcinoma Trial in Shanghai (Cyclophosphamide, Fludarabine, Mutant

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Shanghai, China
    Changhai Hospital
Jun 13, 2022

Kidney Cancer Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (cell infusion)

Recruiting
  • Kidney Cancer
  • cell infusion
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 2, 2022

Advanced Solid Tumor Trial in Dallas (TCRT-ESO-A2)

Withdrawn
  • Advanced Solid Tumor
  • TCRT-ESO-A2
  • (no location specified)
Aug 31, 2022

Advanced Solid Tumor Trial in Beijing (YK0901 cells)

Not yet recruiting
  • Advanced Solid Tumor
  • YK0901 cells
  • Beijing, China
    Department of GI Oncology, Peking University Cancer Hospital
Jun 27, 2023

Celiac Disease Trial in Boston (Gluten Powder)

Recruiting
  • Celiac Disease
  • Gluten Powder
  • Boston, Massachusetts
    Celiac Research Centre Mass General Hospital
Jul 1, 2022

Head Neck Cancer, Cervical Cancer, Non-small Cell Carcinoma Trial in Scottsdale, Chapel Hill (TSC-204-A0201, TSC-204-C0702,

Not yet recruiting
  • Head and Neck Cancer
  • +20 more
  • TSC-204-A0201
  • +4 more
  • Scottsdale, Arizona
  • +1 more
Aug 3, 2023

Advanced Solid Tumor Trial in Bethesda, Boston (STAR0602)

Recruiting
  • Advanced Solid Tumor
  • Bethesda, Maryland
  • +1 more
Jan 6, 2023

Subjects Treated With Autologous T Cells Using Sleeping Beauty

Not yet recruiting
  • Gynecologic Cancer
  • +9 more
  • Neoantigen specific TCR-T cell drug product
  • Houston, Texas
    MD Anderson Cancer Center
Jul 27, 2022